Investor insights
Sectors invested in
Funding rounds participated in
$35M sweet spot round size
Most of their 39 investments are in rounds between $10M and $80M
Investor type
Basic info
Industry
Sectors
Date founded
2016
Investments made
VERALOX Therapeutics raised $24M on June 20, 2023
Investors: Sanofi Ventures, Genesys Capital, Pappas Capital, NYBC Ventures and JDRF T1D Fund
DiogenX raised $30M on May 10, 2023
Investors: AdBio partners, Omnes and JDRF T1D Fund
Inversago Pharma Inc raised $69M on October 17, 2022
Investors: adMare BioInnovations, Forbion, Genesys Capital and JDRF T1D Fund
Kriya Therapeutics raised $270M on May 16, 2022
Investors: Narya, Transhuman Capital, Dexcel Pharma, QVT Financial LLP, Patient Square Capital, Foresite Capital and JDRF T1D Fund
Jaguar Gene Therapy raised undisclosed on March 29, 2022
Investors: JDRF T1D Fund
Biolinq raised $100M on November 2, 2021
Investors: The Broe Group, RiverVest Venture Partners, Global Health Funds, M Ventures, Hikma Ventures, Longevity Vision Fund and JDRF T1D Fund
GentiBio raised $157M on August 11, 2021
Investors: Seattle Children's, RA Capital Management, L.P., OrbiMed Advisors, Avidity Partners and JDRF T1D Fund
Sonoma Biotherapeutics raised $265M on August 4, 2021
Investors: NS Investment, Lilly Asia Ventures, Octagon Capital, Piper Sandler, Osage University Partners (OUP), Lifeforce Capital, Mirae Asset MAPS Global Investments Co., Ltd, Vertex Ventures HC and JDRF T1D Fund
Kriya Therapeutics raised $100M on July 14, 2021
Investors: Narya, Transhuman Capital, QVT Financial LLP, Dexcel Pharma, Foresite Capital, Woodline Partners LP, Patient Square Capital and JDRF T1D Fund
VERALOX Therapeutics raised $17M on June 16, 2021
Investors: Sanofi Ventures, Point Field Partners, VTC Innovation Fund, Genesys Capital, Maryland Momentum Fund, Alumni Ventures Group and JDRF T1D Fund